Biology in Human Welfare - Human Health and Disease - A Brief History of AIDS

• AIDS (Acquired Immunodeficiency Syndrome) is a deadly disease caused by the Human Immunodeficiency Virus (HIV).
• It primarily affects the immune system, leading to the weakening of the body’s ability to fight against infections and diseases.
• The first cases of AIDS were reported in the United States in 1981.
• Since then, AIDS has become a global pandemic, causing millions of deaths worldwide.
• Let’s delve into the history of AIDS and understand its impact on human health.

---

Timeline of AIDS Epidemic

1. 1981: First cases of a mysterious illness reported in homosexual men in Los Angeles and New York.
2. 1982: The term “Acquired Immunodeficiency Syndrome” (AIDS) was coined.
3. 1983: HIV identified as the cause of AIDS by researchers in France and the US.
4. 1985: First commercial blood test approved to diagnose HIV infection.
5. 1987: The first antiretroviral drug, AZT, approved for the treatment of AIDS.
6. 1996: Introduction of Highly Active Antiretroviral Therapy (HAART) revolutionized HIV treatment.
7. 2000: Global initiatives like the UNAIDS program and the “3 by 5” initiative aimed to provide HIV treatment to 3 million people by 2005.
8. 2003: President’s Emergency Plan for AIDS Relief (PEPFAR) launched by the US government.
9. 2007: The number of new HIV infections peaked globally.
10. 2019: Globally, around 38 million people living with HIV/AIDS, with 770,000 deaths reported.

---

Modes of Transmission

• HIV can be transmitted through various routes:

  • Sexual contact with an infected person (unprotected sex).
  • Sharing needles or syringes contaminated with HIV-infected blood.
  • Transfusion of infected blood or blood products.
  • Transmission from HIV-positive mother to her child during pregnancy, childbirth, or breastfeeding.

• It’s important to practice safe sex, avoid sharing needles, and ensure blood/blood products are screened for HIV to prevent transmission.

---

Progression of HIV Infection

1. Primary Infection:

   • Initial exposure to HIV leads to flu-like symptoms (fever, sore throat, rash).
   • Virus replicates rapidly, causing a surge in viral load.

2. Asymptomatic Stage:

   • Following the primary infection, HIV enters a clinically latent stage.
   • Few or no symptoms are observed, but the virus continues to replicate and damage the immune system.

3. Symptomatic Stage:

   • The immune system weakens, and symptoms like persistent fever, weight loss, and frequent infections appear.
   • The patient is highly susceptible to opportunistic infections and cancers.

4. AIDS:

   • CD4+ T-cell count drops below a critical level (<200 cells/μL).
   • Severe immune deficiency, leading to life-threatening opportunistic infections and cancers.

---

Diagnosis of HIV/AIDS

• HIV infection can be diagnosed through various methods:

  1. Antibody Tests:
     • ELISA (Enzyme-Linked Immunosorbent Assay): Detects HIV antibodies in blood.
     • Western Blot: Confirms the presence of antibodies.
  2. Nucleic Acid Tests: Detects viral RNA or DNA in blood (PCR-based tests).
  3. Point-of-Care Tests: Rapid tests providing quick results (detects antibodies or antigens).
     • Oral fluid or fingerstick tests for HIV.
     • Results available within minutes.

• Early detection and diagnosis are crucial for timely treatment and prevention of further transmission.

---

Treatment of AIDS

• Antiretroviral Therapy (ART) is the standard treatment for AIDS.
• ART involves a combination of:
  • Antiretroviral drugs that target different stages of the HIV life cycle.
  • Highly Active Antiretroviral Therapy (HAART) – Combination of three or more drugs.
• Goals of ART:
  • Suppression of viral replication.
  • Restoration and preservation of immune function.
  • Prolonging the progression of HIV infection to AIDS.
• Adherence to ART is essential for its effectiveness.

---

Prevention and Control Strategies

• Prevention is crucial in controlling the spread of HIV/AIDS:

  • Education and awareness programs about safe sex practices.
  • Access to condoms and promotion of their usage.
  • Providing clean needles and syringes to drug users.
  • Blood transfusion screening for HIV.
  • Preventing mother-to-child transmission through antenatal care and HIV testing.

• Vaccines for HIV prevention are under development, but none are currently available.

---

Impact of AIDS on Society and Individuals

• AIDS has had a profound impact on society and individuals:

  • Increased mortality rates, especially in younger adults.
  • Orphanhood due to parental deaths.
  • Economic strain on families and healthcare systems.
  • Stigmatization and discrimination against HIV-positive individuals.
  • Shaping policies and global health strategies.

• Raising awareness, reducing stigma, and ensuring access to treatment and support services are essential for addressing the impact of AIDS.

---

Conclusion

• The history of AIDS highlights the devastating impact of the disease since its emergence.
• Timely diagnosis, effective treatment, and prevention strategies have improved over time.
• Continued efforts are needed to combat HIV/AIDS globally.
• Education, awareness, and commitment to safe practices are crucial in halting the transmission of HIV and reducing the burden of AIDS.

Slide 11

Impact of AIDS on the Immune System

• HIV primarily targets CD4+ T cells, a crucial component of the immune system.
• Progressive loss of CD4+ T cells weakens the immune response.
• Reduced ability to fight off infections and diseases.
• Opportunistic infections become more prevalent (e.g., Pneumocystis pneumonia, tuberculosis).
• Increased risk of certain cancers (e.g., Kaposi’s sarcoma, non-Hodgkin lymphoma).

---

Slide 12

Opportunistic Infections Associated with AIDS

• Opportunistic infections take advantage of the weakened immune system in AIDS patients.
• Examples of opportunistic infections:
  • Candidiasis (yeast infection).
  • Tuberculosis.
  • Cytomegalovirus (CMV) infection.
  • Cryptococcal meningitis.
  • Toxoplasmosis.
  • Pneumocystis pneumonia (PCP).
  • Invasive cervical cancer.

---

Slide 13

Prevention of Mother-to-Child Transmission (PMTCT)

• Vertical transmission of HIV can occur during pregnancy, childbirth, or breastfeeding.
• PMTCT strategies aim to reduce transmission from mother to child.
• Key interventions include:
  • Antenatal care and HIV testing for pregnant women.
  • Administration of antiretroviral therapy (ART) to HIV-positive pregnant women.
  • Provision of safer childbirth practices.
  • Promoting exclusive breastfeeding or providing alternative feeding options.

---

Slide 14

Global Initiatives to Address HIV/AIDS

• The United Nations Program on HIV/AIDS (UNAIDS) coordinates global actions against AIDS.
• “3 by 5” initiative aimed to provide antiretroviral treatment to 3 million people by 2005.
• President’s Emergency Plan for AIDS Relief (PEPFAR) initiated by the US government.
• Global Fund to Fight AIDS, Tuberculosis, and Malaria supports prevention and treatment programs.
• Numerous organizations and NGOs work towards AIDS awareness, prevention, and support.

---

Slide 15

Social Stigma and Discrimination

• People living with HIV/AIDS often face stigma and discrimination.
• Stigmatization leads to secrecy, fear, and denial, hindering prevention and treatment efforts.
• Discrimination affects access to healthcare, employment, education, and social support.
• Addressing stigma is crucial for creating an inclusive and supportive society.

---

Slide 16

Sex Education and Safe Practices

• Comprehensive sex education plays a vital role in HIV prevention.
• Providing accurate information about HIV transmission and prevention methods.
• Promoting safe sex practices, such as condom usage and regular testing.
• Empowering individuals to make informed choices regarding their sexual health.
• Encouraging open dialogue and removing taboos surrounding sexual health.

---

Slide 17

Development of HIV Vaccines

• Vaccine development for HIV has been challenging due to the virus’s ability to mutate rapidly.
• Various vaccine strategies have been explored:
  • Recombinant subunit vaccines.
  • DNA vaccines.
  • Viral vector-based vaccines.
• Ongoing research continues to investigate effective vaccine candidates.

---

Slide 18

Support Services for People Living with HIV/AIDS

• Support services are essential in managing the physical, emotional, and social impact of HIV/AIDS:
  • Counselling and psychological support.
  • Provision of antiretroviral therapy (ART).
  • Support groups for individuals living with HIV/AIDS.
  • Nutritional support and guidance.
  • Community-based programs addressing the needs of affected individuals.

---

Slide 19

Ethical Considerations in HIV/AIDS Research and Treatment

• Ethical issues arise in HIV/AIDS research and treatment:
  • Informed consent of participants in clinical trials.
  • Confidentiality and privacy of HIV-positive individuals.
  • Access to treatment in resource-limited settings.
  • Equity in healthcare service delivery.
  • Balancing individual rights and public health interests.

---

Slide 20

Future Directions in HIV/AIDS Research

• Ongoing research aims to further improve prevention, treatment, and support for individuals affected by HIV/AIDS:
  • Development of effective vaccines.
  • Novel antiretroviral drugs with better efficacy and fewer side effects.
  • Implementation of innovative prevention strategies.
  • Promoting equity in healthcare access for all individuals.
  • Addressing the socioeconomic factors contributing to the spread of HIV/AIDS.
    </li> </ul> </li> </ul> <h2 id="slide-21">Slide 21</h2> <h3 id="role-of-education-in-hivaids-prevention">Role of Education in HIV/AIDS Prevention</h3> <ul> <li>Education plays a crucial role in preventing the spread of HIV/AIDS: <ul> <li>Raising awareness about HIV transmission and prevention methods.</li> <li>Promoting safe practices like condom usage and regular testing.</li> <li>Eliminating misconceptions and reducing stigma.</li> <li>Empowering individuals to make informed decisions regarding their sexual health.</li> <li>Incorporating HIV/AIDS education into school curricula.</li> </ul> </li> </ul> <h2 id="slide-22">Slide 22</h2> <h3 id="impact-of-hivaids-on-developing-countries">Impact of HIV/AIDS on Developing Countries</h3> <ul> <li>Developing countries bear a disproportionate burden of the HIV/AIDS epidemic: <ul> <li>Limited access to healthcare resources and antiretroviral treatment.</li> <li>High prevalence of poverty and lack of education.</li> <li>Weakening of economies due to increased mortality rates and healthcare expenses.</li> <li>Challenges in implementing prevention and control strategies.</li> <li>Global support and partnerships are vital in addressing these challenges.</li> </ul> </li> </ul> <h2 id="slide-23">Slide 23</h2> <h3 id="impact-of-hivaids-on-women">Impact of HIV/AIDS on Women</h3> <ul> <li>Women face unique challenges and vulnerabilities in relation to HIV/AIDS: <ul> <li>Biological factors: Higher risk of heterosexual transmission, especially during unprotected sex.</li> <li>Social and cultural factors: Gender inequality, discrimination, and violence.</li> <li>Increased vulnerability during pregnancy, childbirth, and breastfeeding.</li> <li>Access barriers to healthcare services and prevention methods.</li> <li>Empowering women and promoting gender equality is essential in combatting HIV/AIDS.</li> </ul> </li> </ul> <h2 id="slide-24">Slide 24</h2> <h3 id="role-of-non-governmental-organizations-ngos-in-hivaids">Role of Non-Governmental Organizations (NGOs) in HIV/AIDS</h3> <ul> <li>NGOs play a critical role in HIV/AIDS prevention, treatment, and support: <ul> <li>Community-based organizations provide education and awareness programs.</li> <li>They offer counseling, testing, and support services to affected individuals.</li> <li>NGOs advocate for the rights of people living with HIV/AIDS.</li> <li>They collaborate with government and international agencies to implement prevention strategies.</li> <li>NGOs contribute to research, policy development, and resource mobilization.</li> </ul> </li> </ul> <h2 id="slide-25">Slide 25</h2> <h3 id="challenges-in-hivaids-control-and-prevention">Challenges in HIV/AIDS Control and Prevention</h3> <ul> <li>Despite progress, several challenges remain in controlling the spread of HIV/AIDS: <ul> <li>Stigma and discrimination limiting access to testing and treatment.</li> <li>Limited resources and financial constraints in implementing prevention programs.</li> <li>Inadequate healthcare infrastructure in some regions.</li> <li>Cultural and social barriers that hinder education and awareness efforts.</li> <li>Addressing these challenges requires a multi-faceted approach involving various stakeholders.</li> </ul> </li> </ul> <h2 id="slide-26">Slide 26</h2> <h3 id="ethical-dilemmas-in-hivaids-management">Ethical Dilemmas in HIV/AIDS Management</h3> <ul> <li>Ethical considerations arise in HIV/AIDS healthcare and research: <ul> <li>Balancing individual privacy and public health interests.</li> <li>Ensuring informed consent and confidentiality of patients.</li> <li>Availability and affordability of antiretroviral treatment.</li> <li>Equity in healthcare access for all individuals.</li> <li>Collaborative efforts between healthcare providers, researchers, and policymakers are essential in navigating these dilemmas.</li> </ul> </li> </ul> <h2 id="slide-27">Slide 27</h2> <h3 id="economic-impact-of-hivaids">Economic Impact of HIV/AIDS</h3> <ul> <li>HIV/AIDS has significant economic implications: <ul> <li>Loss of workforce productivity due to morbidity and mortality.</li> <li>Increased healthcare expenditures, straining national budgets.</li> <li>Impact on household income and poverty levels.</li> <li>Disruption of education and social services.</li> <li>Mitigating the economic impact requires investment in prevention, treatment, and social support programs.</li> </ul> </li> </ul> <h2 id="slide-28">Slide 28</h2> <h3 id="role-of-media-in-hivaids-awareness">Role of Media in HIV/AIDS Awareness</h3> <ul> <li>Media plays a crucial role in raising awareness and combating stigma associated with HIV/AIDS: <ul> <li>Dissemination of accurate information and prevention messages.</li> <li>Portrayal of HIV/AIDS stories to reduce discrimination and promote empathy.</li> <li>Collaboration with healthcare professionals and NGOs to deliver educational content.</li> <li>Effective use of media platforms to reach diverse populations.</li> <li>Media campaigns can promote safe practices, encourage testing, and challenge societal norms.</li> </ul> </li> </ul> <h2 id="slide-29">Slide 29</h2> <h3 id="role-of-government-in-hivaids-control">Role of Government in HIV/AIDS Control</h3> <ul> <li>Governments play a critical role in HIV/AIDS control and prevention: <ul> <li>Developing and implementing national strategies and policies.</li> <li>Allocating resources for prevention, treatment, and support services.</li> <li>Strengthening healthcare infrastructure and workforce capacity.</li> <li>Advocating for human rights and combating stigma and discrimination.</li> <li>Collaborating with international organizations and agencies for global coordination.</li> </ul> </li> </ul> <h2 id="slide-30">Slide 30</h2> <h3 id="contributions-of-scientific-research-in-hivaids">Contributions of Scientific Research in HIV/AIDS</h3> <ul> <li>Scientific research has made significant contributions to our understanding and management of HIV/AIDS: <ul> <li>Identification of HIV as the causative agent of AIDS.</li> <li>Development of diagnostic tests and screening methods.</li> <li>Discovery of antiretroviral drugs and treatment strategies.</li> <li>Advancements in vaccine development and preventive measures.</li> <li>Ongoing research continues to expand our knowledge and improve the outcomes for individuals affected by HIV/AIDS.</li> </ul> </li> </ul> </div> </div> <script src="/reveal/dist/reveal.js"></script> <script src="/reveal/plugin/markdown/markdown.js"></script> <script src="/reveal/plugin/highlight/highlight.js"></script> <script src="/reveal/plugin/math/math.js"></script> <script src="/reveal/plugin/anything/plugin.js"></script> <script src="/reveal/plugin/notes/notes.js"></script> <script src="/reveal/plugin/chart/Chart.min.js"></script> <script src="/reveal/plugin/chart/plugin.js"></script> <script src="/reveal/plugin/menu/menu.js"></script> <script src="/reveal/plugin/highlight/highlight.js"></script> <script src="/reveal/plugin/audio-slideshow/plugin.js"></script> <script src="/reveal/plugin/audio-slideshow/recorder.js"></script> <script src="/reveal/plugin/audio-slideshow/RecordRTC.js"></script> <script src="/reveal/plugin/copycode/copycode.js"></script> <script src="/reveal/plugin/RevealEditor-master/revealeditor.js"></script> <script src="/reveal/plugin/jump/jump.js"></script> <script src="/reveal/plugin/zoom/zoom.js"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js"></script> <script> Reveal.initialize({ slideNumber: true, controls: true, controlsTutorial: true, progress: true, transition: 'fade', highlight: { escapeHTML: false }, customcontrols: { controls: [ { icon: '<i class="fa fa-pen-square"></i>', title: 'Toggle chalkboard (B)', action: 'RevealChalkboard.toggleChalkboard();' }, { icon: '<i class="fa fa-pen"></i>', title: 'Toggle notes canvas (C)', action: 'RevealChalkboard.toggleNotesCanvas();' } ] }, plugins: [RevealMath.KaTeX,RevealMarkdown, RevealHighlight, RevealNotes, RevealAnything, RevealMenu, RevealChalkboard, RevealChart, RevealAudioSlideshow, RevealAudioRecorder, CopyCode, RevealZoom], }); function transformCallouts() { var slides = document.querySelectorAll('.reveal .slides section'); slides.forEach(function (slide) { var data = document.getElementsByTagName("Success"); for (let i = 0; i < data.length; i++) { data[i].classList.add("callout"); data[i].classList.add("callout-success"); } var data = document.getElementsByTagName("Default"); for (let i = 0; i < data.length; i++) { data[i].classList.add("callout"); data[i].classList.add("callout-default"); } var data = document.getElementsByTagName("Warning"); for (let i = 0; i < data.length; i++) { data[i].classList.add("callout"); data[i].classList.add("callout-warning"); } var data = document.getElementsByTagName("Primary"); for (let i = 0; i < data.length; i++) { data[i].classList.add("callout"); data[i].classList.add("callout-primary"); } var data = document.getElementsByTagName("Danger"); for (let i = 0; i < data.length; i++) { data[i].classList.add("callout"); data[i].classList.add("callout-danger"); } }); }; function addrfit() { var slides = document.querySelectorAll('.reveal'); slides.forEach(function (slide) { var temp = document.getElementsByTagName("h2"); if (temp.length > 0) { for (let i = 0; i < temp.length; i++) { temp[i].classList.add("r-fit-text"); } } var temp3 = document.getElementsByTagName("h1"); if (temp3.length > 0) { for (let i = 0; i < temp3.length; i++) { temp3[i].classList.add("r-fit-text"); } } var temp6 = document.getElementsByClassName("text-container"); if (temp6.length > 0) { for (let i = 0; i < temp6.length; i++) { var charcount = 0; var ptags = temp6[i].getElementsByTagName("p"); try { for (let j = 0; j < ptags.length; j++) { temp = ptags[j].outerText.replaceAll(" ", ""); temp = temp.replaceAll("\n", ""); charcount += temp.length; } } catch (err) { console.log(err); } var font = 35; if (charcount > 50 && charcount < 100) { font = 35; } else if (charcount > 100 && charcount < 120) { font = 33; } else if (charcount > 120 && charcount < 150) { font = 33; } else if (charcount > 150 && charcount < 170) { font = 31; } else if (charcount > 170 && charcount < 200) { font = 30; } else if (charcount > 200 && charcount < 230) { font = 29; } else if (charcount > 230 && charcount < 250) { font = 28; } else if (charcount > 250 && charcount < 270) { font = 27; } else if (charcount > 270 && charcount < 300) { font = 25; } else if (charcount > 300 && charcount < 330) { font = 23; } else if (charcount > 330 && charcount < 360) { font = 24; } else if (charcount > 360 && charcount < 390) { font = 22; } else if (charcount > 390 && charcount < 420) { font = 21; } else if (charcount > 420) { font = 20; } temp6[i].style.fontSize = `${font}px`; } } }) } Reveal.addEventListener('ready', addrfit); Reveal.addEventListener('ready', transformCallouts); </script> <script> function adjustFontSize(element) { let fontSize = parseInt(window.getComputedStyle(element).fontSize); const parentWidth = element.parentNode.offsetWidth; while (element.scrollHeight > element.offsetHeight || element.scrollWidth > parentWidth) { fontSize -= 1; element.style.fontSize = fontSize + 'px'; } } function checkOverflow() { const elements = document.querySelectorAll('.left, .right'); elements.forEach(element => { adjustFontSize(element); }); } window.addEventListener('load', checkOverflow); window.addEventListener('resize', checkOverflow); </script> </body> </html>